| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 163 | 2022 | 1535 | 17.470 |
Why?
|
| Blood Pressure | 81 | 2022 | 1451 | 7.690 |
Why?
|
| Stroke | 87 | 2023 | 2163 | 6.570 |
Why?
|
| Antihypertensive Agents | 58 | 2021 | 498 | 6.020 |
Why?
|
| Cardiovascular Diseases | 47 | 2022 | 940 | 4.390 |
Why?
|
| Blood Pressure Determination | 22 | 2022 | 152 | 4.090 |
Why?
|
| American Heart Association | 32 | 2021 | 142 | 3.660 |
Why?
|
| Risk Factors | 112 | 2022 | 5731 | 2.310 |
Why?
|
| Humans | 324 | 2023 | 68618 | 2.310 |
Why?
|
| Practice Guidelines as Topic | 19 | 2019 | 772 | 1.960 |
Why?
|
| Life Style | 19 | 2021 | 338 | 1.930 |
Why?
|
| Male | 177 | 2022 | 37321 | 1.670 |
Why?
|
| Heart Diseases | 19 | 2020 | 276 | 1.640 |
Why?
|
| Sodium Chloride, Dietary | 9 | 2022 | 50 | 1.640 |
Why?
|
| Middle Aged | 138 | 2022 | 21147 | 1.570 |
Why?
|
| Female | 178 | 2022 | 38074 | 1.570 |
Why?
|
| Aged | 108 | 2022 | 14862 | 1.500 |
Why?
|
| Societies, Medical | 13 | 2017 | 403 | 1.480 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 8 | 2021 | 89 | 1.440 |
Why?
|
| Diabetes Mellitus | 22 | 2022 | 694 | 1.410 |
Why?
|
| Brain Ischemia | 7 | 2023 | 665 | 1.410 |
Why?
|
| Health Promotion | 12 | 2017 | 407 | 1.370 |
Why?
|
| Disease Management | 7 | 2018 | 248 | 1.350 |
Why?
|
| Prevalence | 45 | 2021 | 1619 | 1.340 |
Why?
|
| United States | 80 | 2021 | 7367 | 1.320 |
Why?
|
| Global Health | 13 | 2021 | 136 | 1.270 |
Why?
|
| Residence Characteristics | 7 | 2017 | 252 | 1.150 |
Why?
|
| International Agencies | 9 | 2017 | 17 | 1.140 |
Why?
|
| South Carolina | 64 | 2018 | 2752 | 1.070 |
Why?
|
| Adult | 109 | 2023 | 21403 | 1.070 |
Why?
|
| Cerebrovascular Disorders | 6 | 2018 | 182 | 1.030 |
Why?
|
| Health Personnel | 6 | 2023 | 286 | 1.020 |
Why?
|
| Sodium | 4 | 2022 | 161 | 1.020 |
Why?
|
| Diet, Sodium-Restricted | 9 | 2020 | 45 | 1.000 |
Why?
|
| Risk Assessment | 26 | 2021 | 2007 | 0.990 |
Why?
|
| Sodium, Dietary | 10 | 2016 | 31 | 0.980 |
Why?
|
| Hospitalization | 10 | 2016 | 978 | 0.900 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2020 | 931 | 0.880 |
Why?
|
| Incidence | 29 | 2022 | 1603 | 0.880 |
Why?
|
| Coronary Artery Disease | 9 | 2021 | 696 | 0.880 |
Why?
|
| Metabolic Syndrome | 8 | 2015 | 191 | 0.880 |
Why?
|
| Biomedical Research | 6 | 2020 | 310 | 0.870 |
Why?
|
| Global Burden of Disease | 2 | 2019 | 4 | 0.870 |
Why?
|
| Ischemic Attack, Transient | 2 | 2021 | 167 | 0.830 |
Why?
|
| Healthcare Disparities | 5 | 2018 | 378 | 0.800 |
Why?
|
| Mass Screening | 8 | 2018 | 843 | 0.780 |
Why?
|
| Birth Weight | 6 | 2009 | 186 | 0.760 |
Why?
|
| Cardiology | 6 | 2018 | 140 | 0.730 |
Why?
|
| Kidney Failure, Chronic | 12 | 2014 | 365 | 0.730 |
Why?
|
| Public Policy | 3 | 2019 | 71 | 0.730 |
Why?
|
| Aged, 80 and over | 22 | 2019 | 4848 | 0.720 |
Why?
|
| Body Mass Index | 11 | 2018 | 867 | 0.720 |
Why?
|
| Population Surveillance | 12 | 2018 | 285 | 0.710 |
Why?
|
| Cost of Illness | 8 | 2018 | 206 | 0.700 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2019 | 7 | 0.700 |
Why?
|
| Evidence-Based Medicine | 7 | 2018 | 438 | 0.690 |
Why?
|
| Medication Adherence | 4 | 2017 | 335 | 0.680 |
Why?
|
| Recommended Dietary Allowances | 1 | 2019 | 10 | 0.670 |
Why?
|
| Health Status Disparities | 6 | 2020 | 326 | 0.660 |
Why?
|
| Kidney Diseases | 3 | 2022 | 307 | 0.650 |
Why?
|
| Adolescent | 43 | 2023 | 8912 | 0.630 |
Why?
|
| Reticular Formation | 1 | 2018 | 13 | 0.630 |
Why?
|
| Prehypertension | 6 | 2021 | 40 | 0.620 |
Why?
|
| Neurophysiology | 1 | 2018 | 17 | 0.620 |
Why?
|
| Stroke Rehabilitation | 4 | 2020 | 335 | 0.610 |
Why?
|
| Pandemics | 2 | 2021 | 352 | 0.590 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.580 |
Why?
|
| Community Networks | 3 | 2011 | 96 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.580 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2022 | 28 | 0.570 |
Why?
|
| Students, Dental | 2 | 2007 | 49 | 0.570 |
Why?
|
| Patient Selection | 2 | 2020 | 592 | 0.560 |
Why?
|
| Education, Dental | 2 | 2007 | 63 | 0.560 |
Why?
|
| Southeastern United States | 15 | 2013 | 281 | 0.560 |
Why?
|
| Dementia | 4 | 2018 | 158 | 0.550 |
Why?
|
| Periodicals as Topic | 3 | 2018 | 158 | 0.540 |
Why?
|
| Cohort Studies | 28 | 2021 | 2358 | 0.540 |
Why?
|
| Age Factors | 21 | 2021 | 1864 | 0.530 |
Why?
|
| Coronary Disease | 8 | 2021 | 358 | 0.530 |
Why?
|
| Health Expenditures | 2 | 2015 | 170 | 0.530 |
Why?
|
| Primary Health Care | 10 | 2019 | 703 | 0.520 |
Why?
|
| Community Health Services | 5 | 2011 | 141 | 0.520 |
Why?
|
| Severity of Illness Index | 13 | 2021 | 1851 | 0.510 |
Why?
|
| Follow-Up Studies | 21 | 2021 | 3259 | 0.510 |
Why?
|
| Clinical Competence | 3 | 2017 | 657 | 0.510 |
Why?
|
| Benzimidazoles | 2 | 2014 | 128 | 0.510 |
Why?
|
| Health Education | 2 | 2017 | 279 | 0.500 |
Why?
|
| Infant, Low Birth Weight | 6 | 2006 | 84 | 0.500 |
Why?
|
| Time Factors | 13 | 2021 | 4655 | 0.500 |
Why?
|
| Age Distribution | 11 | 2015 | 320 | 0.500 |
Why?
|
| Socioeconomic Factors | 14 | 2021 | 955 | 0.500 |
Why?
|
| Ramipril | 1 | 2014 | 10 | 0.490 |
Why?
|
| Benzoates | 1 | 2014 | 20 | 0.480 |
Why?
|
| Delivery of Health Care | 3 | 2017 | 445 | 0.480 |
Why?
|
| Sarcoidosis, Pulmonary | 2 | 2012 | 17 | 0.480 |
Why?
|
| Cerebral Revascularization | 1 | 2014 | 45 | 0.480 |
Why?
|
| Emergency Treatment | 1 | 2014 | 52 | 0.470 |
Why?
|
| Obesity | 12 | 2021 | 1076 | 0.470 |
Why?
|
| Nigeria | 11 | 2023 | 35 | 0.460 |
Why?
|
| Education, Medical, Continuing | 7 | 2014 | 136 | 0.450 |
Why?
|
| Racism | 1 | 2014 | 59 | 0.450 |
Why?
|
| Sex Factors | 19 | 2019 | 1266 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2013 | 529 | 0.440 |
Why?
|
| Myocardial Infarction | 9 | 2017 | 807 | 0.440 |
Why?
|
| Young Adult | 22 | 2022 | 5717 | 0.440 |
Why?
|
| Atherosclerosis | 1 | 2015 | 204 | 0.440 |
Why?
|
| Sex Distribution | 10 | 2015 | 274 | 0.440 |
Why?
|
| Awareness | 5 | 2017 | 81 | 0.420 |
Why?
|
| Sarcoidosis | 6 | 2008 | 77 | 0.410 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 123 | 0.410 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 425 | 0.410 |
Why?
|
| Proportional Hazards Models | 13 | 2018 | 792 | 0.410 |
Why?
|
| Evidence-Based Practice | 2 | 2013 | 146 | 0.410 |
Why?
|
| Case-Control Studies | 11 | 2022 | 1553 | 0.410 |
Why?
|
| Environmental Exposure | 6 | 2017 | 269 | 0.410 |
Why?
|
| Cholesterol | 7 | 2019 | 331 | 0.400 |
Why?
|
| Ghana | 9 | 2023 | 40 | 0.390 |
Why?
|
| Exercise | 4 | 2018 | 658 | 0.380 |
Why?
|
| Research Report | 5 | 2017 | 35 | 0.380 |
Why?
|
| Occupational Exposure | 7 | 2013 | 122 | 0.370 |
Why?
|
| Noncommunicable Diseases | 2 | 2021 | 7 | 0.370 |
Why?
|
| Glucocorticoids | 1 | 2012 | 222 | 0.370 |
Why?
|
| Asia | 2 | 2021 | 59 | 0.360 |
Why?
|
| Motor Activity | 2 | 2013 | 621 | 0.360 |
Why?
|
| Drug Resistance | 4 | 2015 | 223 | 0.360 |
Why?
|
| Program Evaluation | 8 | 2018 | 502 | 0.350 |
Why?
|
| Health Policy | 4 | 2016 | 221 | 0.350 |
Why?
|
| Sickle Cell Trait | 2 | 2021 | 24 | 0.340 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 202 | 0.340 |
Why?
|
| Cross-Sectional Studies | 14 | 2018 | 2279 | 0.340 |
Why?
|
| Brain Injuries | 2 | 2009 | 268 | 0.340 |
Why?
|
| Lipoproteins | 5 | 2013 | 161 | 0.330 |
Why?
|
| Vaccination | 1 | 2011 | 189 | 0.330 |
Why?
|
| Survival Rate | 10 | 2021 | 1056 | 0.330 |
Why?
|
| Dyslipidemias | 3 | 2021 | 98 | 0.330 |
Why?
|
| Diet | 8 | 2022 | 514 | 0.330 |
Why?
|
| Communication | 2 | 2011 | 329 | 0.320 |
Why?
|
| Needs Assessment | 3 | 2016 | 186 | 0.320 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2022 | 127 | 0.310 |
Why?
|
| Prognosis | 11 | 2019 | 2093 | 0.310 |
Why?
|
| Multiple Organ Failure | 1 | 2008 | 36 | 0.310 |
Why?
|
| Self Care | 1 | 2011 | 253 | 0.310 |
Why?
|
| Comorbidity | 12 | 2021 | 1426 | 0.310 |
Why?
|
| Logistic Models | 14 | 2018 | 1420 | 0.310 |
Why?
|
| Advisory Committees | 3 | 2017 | 73 | 0.310 |
Why?
|
| Activities of Daily Living | 4 | 2020 | 319 | 0.300 |
Why?
|
| Social Class | 5 | 2019 | 127 | 0.300 |
Why?
|
| World Health Organization | 6 | 2018 | 53 | 0.300 |
Why?
|
| Hyperlipidemias | 5 | 2015 | 90 | 0.290 |
Why?
|
| Diabetic Angiopathies | 6 | 2008 | 203 | 0.290 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2019 | 140 | 0.290 |
Why?
|
| Professional-Patient Relations | 1 | 2007 | 71 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 2 | 2020 | 198 | 0.290 |
Why?
|
| Cognitive Dysfunction | 3 | 2018 | 176 | 0.290 |
Why?
|
| Primary Prevention | 3 | 2013 | 115 | 0.280 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2013 | 161 | 0.280 |
Why?
|
| Physicians, Family | 2 | 2014 | 83 | 0.270 |
Why?
|
| Research | 2 | 2018 | 214 | 0.270 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2014 | 202 | 0.270 |
Why?
|
| Teaching | 2 | 2007 | 169 | 0.270 |
Why?
|
| History, 21st Century | 2 | 2018 | 127 | 0.270 |
Why?
|
| Clinical Trials as Topic | 6 | 2018 | 848 | 0.270 |
Why?
|
| Atrial Fibrillation | 3 | 2018 | 249 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 767 | 0.270 |
Why?
|
| Heart Failure | 7 | 2021 | 1180 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 786 | 0.270 |
Why?
|
| Vegetables | 3 | 2022 | 76 | 0.270 |
Why?
|
| Retrospective Studies | 16 | 2022 | 7277 | 0.270 |
Why?
|
| History, 20th Century | 2 | 2018 | 248 | 0.260 |
Why?
|
| Patient Care Team | 4 | 2017 | 311 | 0.260 |
Why?
|
| Genomics | 3 | 2017 | 168 | 0.260 |
Why?
|
| Africa, Western | 6 | 2022 | 15 | 0.250 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 174 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2023 | 3705 | 0.250 |
Why?
|
| Diabetic Nephropathies | 4 | 2010 | 161 | 0.250 |
Why?
|
| Child | 16 | 2021 | 6405 | 0.240 |
Why?
|
| Databases, Factual | 8 | 2018 | 622 | 0.240 |
Why?
|
| Mouth Neoplasms | 1 | 2007 | 206 | 0.240 |
Why?
|
| Medically Underserved Area | 2 | 2005 | 85 | 0.240 |
Why?
|
| Prejudice | 2 | 2009 | 37 | 0.240 |
Why?
|
| Longitudinal Studies | 6 | 2016 | 1054 | 0.230 |
Why?
|
| Health Maintenance Organizations | 2 | 2016 | 22 | 0.230 |
Why?
|
| Disease Progression | 6 | 2012 | 1038 | 0.230 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2004 | 95 | 0.230 |
Why?
|
| Systole | 3 | 2019 | 149 | 0.230 |
Why?
|
| Lung Neoplasms | 4 | 2010 | 1173 | 0.230 |
Why?
|
| Early Diagnosis | 2 | 2017 | 122 | 0.220 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 1465 | 0.220 |
Why?
|
| Disability Evaluation | 4 | 2020 | 298 | 0.220 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 240 | 0.220 |
Why?
|
| Cost-Benefit Analysis | 5 | 2017 | 504 | 0.220 |
Why?
|
| Curriculum | 2 | 2007 | 575 | 0.220 |
Why?
|
| Geography | 5 | 2019 | 80 | 0.220 |
Why?
|
| Public Health Informatics | 1 | 2003 | 7 | 0.220 |
Why?
|
| Pneumonia, Aspiration | 1 | 2023 | 22 | 0.220 |
Why?
|
| Disabled Persons | 2 | 2018 | 94 | 0.220 |
Why?
|
| Infant, Newborn | 10 | 2021 | 2455 | 0.220 |
Why?
|
| Disclosure | 1 | 2023 | 45 | 0.210 |
Why?
|
| SEER Program | 1 | 2003 | 153 | 0.210 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 839 | 0.210 |
Why?
|
| Health Status | 3 | 2020 | 429 | 0.200 |
Why?
|
| Glomerular Filtration Rate | 4 | 2013 | 274 | 0.200 |
Why?
|
| Child, Preschool | 9 | 2016 | 3187 | 0.200 |
Why?
|
| Prediabetic State | 1 | 2022 | 48 | 0.200 |
Why?
|
| Death, Sudden | 2 | 2018 | 24 | 0.200 |
Why?
|
| Blood Flow Velocity | 2 | 2020 | 172 | 0.200 |
Why?
|
| Patient Discharge | 2 | 2014 | 294 | 0.200 |
Why?
|
| Women's Health | 3 | 2015 | 148 | 0.200 |
Why?
|
| Preventive Health Services | 3 | 2020 | 86 | 0.200 |
Why?
|
| India | 1 | 2021 | 41 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 154 | 0.200 |
Why?
|
| Food Industry | 3 | 2022 | 7 | 0.200 |
Why?
|
| Alcohol Drinking | 3 | 2019 | 805 | 0.200 |
Why?
|
| Eclampsia | 1 | 2021 | 16 | 0.200 |
Why?
|
| Lipoproteins, LDL | 5 | 2015 | 343 | 0.200 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2017 | 106 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 1085 | 0.190 |
Why?
|
| Body Weight | 4 | 2014 | 554 | 0.190 |
Why?
|
| Nutritional Status | 2 | 2019 | 112 | 0.190 |
Why?
|
| Interdisciplinary Research | 1 | 2021 | 4 | 0.190 |
Why?
|
| Schools, Medical | 3 | 2000 | 157 | 0.190 |
Why?
|
| Health Services Accessibility | 8 | 2019 | 581 | 0.190 |
Why?
|
| Counseling | 2 | 2017 | 280 | 0.190 |
Why?
|
| Attitude to Health | 5 | 2012 | 403 | 0.190 |
Why?
|
| Registries | 5 | 2018 | 733 | 0.190 |
Why?
|
| Organizations | 5 | 2020 | 16 | 0.190 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 1140 | 0.190 |
Why?
|
| Smoking | 9 | 2019 | 1452 | 0.180 |
Why?
|
| Africa | 5 | 2022 | 41 | 0.180 |
Why?
|
| Dietary Carbohydrates | 1 | 2000 | 27 | 0.180 |
Why?
|
| Models, Educational | 2 | 2014 | 67 | 0.180 |
Why?
|
| Pregnancy | 6 | 2022 | 2334 | 0.180 |
Why?
|
| Renin-Angiotensin System | 1 | 2000 | 79 | 0.180 |
Why?
|
| Clinical Protocols | 2 | 2018 | 172 | 0.180 |
Why?
|
| Albuminuria | 5 | 2013 | 171 | 0.180 |
Why?
|
| Mentoring | 1 | 2020 | 53 | 0.170 |
Why?
|
| Brazil | 1 | 2019 | 48 | 0.170 |
Why?
|
| Patient Generated Health Data | 1 | 2019 | 10 | 0.170 |
Why?
|
| Internationality | 2 | 2017 | 74 | 0.170 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 84 | 0.170 |
Why?
|
| Serum Amyloid A Protein | 1 | 2019 | 33 | 0.170 |
Why?
|
| Diabetes Complications | 5 | 2010 | 249 | 0.170 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 191 | 0.170 |
Why?
|
| Urine Specimen Collection | 1 | 2019 | 1 | 0.170 |
Why?
|
| Infant | 7 | 2016 | 2891 | 0.170 |
Why?
|
| Multivariate Analysis | 6 | 2015 | 1046 | 0.170 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 2019 | 30 | 0.170 |
Why?
|
| Recovery of Function | 2 | 2020 | 506 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2019 | 39 | 0.170 |
Why?
|
| Rural Health | 4 | 2006 | 66 | 0.170 |
Why?
|
| Demography | 4 | 2015 | 279 | 0.170 |
Why?
|
| International Classification of Diseases | 3 | 2014 | 85 | 0.160 |
Why?
|
| Mortality | 4 | 2014 | 163 | 0.160 |
Why?
|
| Radiobiology | 1 | 2018 | 2 | 0.160 |
Why?
|
| Echocardiography | 2 | 2019 | 515 | 0.160 |
Why?
|
| Patient Participation | 1 | 2020 | 146 | 0.160 |
Why?
|
| Treatment Outcome | 8 | 2018 | 7029 | 0.160 |
Why?
|
| Odds Ratio | 6 | 2022 | 880 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.160 |
Why?
|
| Blood Glucose | 4 | 2022 | 631 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2008 | 468 | 0.160 |
Why?
|
| Health Care Costs | 4 | 2017 | 346 | 0.160 |
Why?
|
| Physician Assistants | 1 | 1999 | 47 | 0.160 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 80 | 0.160 |
Why?
|
| Drug Combinations | 1 | 2019 | 304 | 0.160 |
Why?
|
| Journalism, Medical | 1 | 2018 | 2 | 0.160 |
Why?
|
| Microglia | 1 | 2019 | 143 | 0.160 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2018 | 22 | 0.160 |
Why?
|
| Italy | 1 | 2018 | 36 | 0.160 |
Why?
|
| Nurse Practitioners | 1 | 1999 | 90 | 0.160 |
Why?
|
| Nutrition Surveys | 3 | 2008 | 208 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 277 | 0.150 |
Why?
|
| Brain Stem | 1 | 2018 | 46 | 0.150 |
Why?
|
| Ethics Consultation | 1 | 2018 | 5 | 0.150 |
Why?
|
| Surveys and Questionnaires | 9 | 2016 | 2800 | 0.150 |
Why?
|
| Consultants | 1 | 2018 | 12 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.150 |
Why?
|
| Water Supply | 2 | 2010 | 54 | 0.150 |
Why?
|
| Electronic Health Records | 2 | 2011 | 374 | 0.150 |
Why?
|
| Medically Uninsured | 1 | 1998 | 99 | 0.150 |
Why?
|
| Body Height | 3 | 2007 | 67 | 0.150 |
Why?
|
| Insulin | 1 | 2000 | 619 | 0.150 |
Why?
|
| Phenotype | 3 | 2017 | 947 | 0.140 |
Why?
|
| Radiation Dosage | 2 | 2018 | 419 | 0.140 |
Why?
|
| Blood Pressure Monitors | 1 | 2016 | 2 | 0.140 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 318 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2016 | 99 | 0.130 |
Why?
|
| Marketing | 1 | 2016 | 26 | 0.130 |
Why?
|
| Neoplasms | 4 | 2011 | 1667 | 0.130 |
Why?
|
| Onychomycosis | 1 | 1995 | 6 | 0.130 |
Why?
|
| Aircraft | 3 | 2000 | 30 | 0.130 |
Why?
|
| Attitude of Health Personnel | 2 | 2017 | 442 | 0.130 |
Why?
|
| Fluconazole | 1 | 1995 | 26 | 0.130 |
Why?
|
| Multilingualism | 1 | 2015 | 14 | 0.130 |
Why?
|
| Carotid Artery, Internal | 2 | 2006 | 85 | 0.130 |
Why?
|
| Heart Rate | 2 | 2017 | 568 | 0.130 |
Why?
|
| Public Health | 1 | 1998 | 201 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 481 | 0.130 |
Why?
|
| Health Plan Implementation | 1 | 2015 | 37 | 0.130 |
Why?
|
| Public Health Administration | 1 | 1996 | 36 | 0.130 |
Why?
|
| Lung | 3 | 2012 | 849 | 0.130 |
Why?
|
| California | 2 | 2016 | 99 | 0.130 |
Why?
|
| Epilepsy | 2 | 2009 | 336 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2015 | 85 | 0.130 |
Why?
|
| Telephone | 2 | 2014 | 160 | 0.130 |
Why?
|
| Anemia, Sickle Cell | 2 | 2016 | 364 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 1995 | 108 | 0.120 |
Why?
|
| Age of Onset | 2 | 2013 | 188 | 0.120 |
Why?
|
| Risk | 3 | 2013 | 563 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2014 | 239 | 0.120 |
Why?
|
| Aspirin | 2 | 2013 | 295 | 0.120 |
Why?
|
| Urban Health | 3 | 2006 | 49 | 0.120 |
Why?
|
| Guideline Adherence | 3 | 2016 | 287 | 0.120 |
Why?
|
| Electrocardiography | 2 | 2017 | 601 | 0.120 |
Why?
|
| International Cooperation | 1 | 2015 | 88 | 0.120 |
Why?
|
| Social Participation | 1 | 2014 | 16 | 0.120 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2015 | 88 | 0.120 |
Why?
|
| Community-Based Participatory Research | 1 | 2016 | 133 | 0.120 |
Why?
|
| Fruit | 3 | 2022 | 86 | 0.120 |
Why?
|
| Cause of Death | 5 | 2021 | 241 | 0.120 |
Why?
|
| Disease | 1 | 2014 | 41 | 0.120 |
Why?
|
| Algorithms | 4 | 2015 | 1196 | 0.120 |
Why?
|
| Potassium | 1 | 2014 | 168 | 0.120 |
Why?
|
| Remote Consultation | 1 | 2014 | 50 | 0.120 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2014 | 10 | 0.120 |
Why?
|
| Association | 1 | 2013 | 5 | 0.120 |
Why?
|
| Database Management Systems | 2 | 2004 | 25 | 0.120 |
Why?
|
| Occupational Diseases | 3 | 2005 | 68 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2014 | 141 | 0.110 |
Why?
|
| Telemedicine | 2 | 2014 | 700 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 212 | 0.110 |
Why?
|
| Automobile Driving | 1 | 2014 | 88 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2013 | 51 | 0.110 |
Why?
|
| Musculoskeletal Diseases | 1 | 2013 | 45 | 0.110 |
Why?
|
| Radioactive Pollutants | 2 | 2005 | 10 | 0.110 |
Why?
|
| Renal Insufficiency | 3 | 2018 | 121 | 0.110 |
Why?
|
| Confidence Intervals | 4 | 2015 | 242 | 0.110 |
Why?
|
| Population Groups | 1 | 2013 | 16 | 0.110 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2010 | 76 | 0.110 |
Why?
|
| Catheterization | 1 | 2013 | 209 | 0.110 |
Why?
|
| Environmental Health | 1 | 1992 | 23 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 82 | 0.100 |
Why?
|
| Morbidity | 2 | 2013 | 130 | 0.100 |
Why?
|
| Respiratory Function Tests | 1 | 2012 | 123 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2014 | 384 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 99 | 0.100 |
Why?
|
| Maternal Mortality | 2 | 2021 | 16 | 0.100 |
Why?
|
| Biopsy | 2 | 2012 | 540 | 0.100 |
Why?
|
| Health Status Indicators | 3 | 2018 | 117 | 0.100 |
Why?
|
| Orthopedic Procedures | 1 | 2013 | 102 | 0.100 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 99 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2012 | 219 | 0.100 |
Why?
|
| Waist Circumference | 3 | 2018 | 32 | 0.100 |
Why?
|
| Quality of Life | 2 | 2017 | 1515 | 0.100 |
Why?
|
| Aerospace Medicine | 3 | 2001 | 22 | 0.100 |
Why?
|
| Soil | 1 | 2012 | 51 | 0.100 |
Why?
|
| Cholesterol, LDL | 5 | 2006 | 161 | 0.100 |
Why?
|
| Brachial Artery | 2 | 2008 | 34 | 0.100 |
Why?
|
| Chi-Square Distribution | 5 | 2013 | 546 | 0.100 |
Why?
|
| Databases as Topic | 1 | 2011 | 49 | 0.100 |
Why?
|
| Electromagnetic Fields | 3 | 2000 | 66 | 0.100 |
Why?
|
| Staff Development | 1 | 2011 | 35 | 0.090 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2010 | 79 | 0.090 |
Why?
|
| Research Design | 4 | 2016 | 729 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 201 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 1992 | 221 | 0.090 |
Why?
|
| Nutrition Assessment | 1 | 1990 | 43 | 0.090 |
Why?
|
| Income | 3 | 2021 | 167 | 0.090 |
Why?
|
| Data Collection | 5 | 2005 | 420 | 0.090 |
Why?
|
| Radiation Injuries | 1 | 2011 | 97 | 0.090 |
Why?
|
| Poverty | 2 | 2004 | 219 | 0.090 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 65 | 0.090 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2013 | 348 | 0.090 |
Why?
|
| Dietary Fats | 1 | 1990 | 103 | 0.090 |
Why?
|
| Health Surveys | 6 | 2014 | 489 | 0.090 |
Why?
|
| Athletic Injuries | 2 | 1982 | 73 | 0.090 |
Why?
|
| Sewage | 1 | 2010 | 23 | 0.090 |
Why?
|
| Quality of Health Care | 3 | 2019 | 322 | 0.090 |
Why?
|
| Water Microbiology | 1 | 2010 | 24 | 0.090 |
Why?
|
| Nuclear Reactors | 1 | 2010 | 8 | 0.090 |
Why?
|
| Cosmic Radiation | 2 | 2000 | 6 | 0.090 |
Why?
|
| Recurrence | 2 | 2009 | 948 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2010 | 40 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2014 | 413 | 0.090 |
Why?
|
| Developing Countries | 2 | 2021 | 106 | 0.090 |
Why?
|
| Overweight | 2 | 2010 | 186 | 0.090 |
Why?
|
| England | 2 | 2014 | 64 | 0.090 |
Why?
|
| Helicobacter pylori | 1 | 2010 | 54 | 0.090 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 80 | 0.080 |
Why?
|
| Tunica Media | 2 | 2006 | 33 | 0.080 |
Why?
|
| Health Planning Guidelines | 1 | 2009 | 23 | 0.080 |
Why?
|
| Tunica Intima | 2 | 2006 | 59 | 0.080 |
Why?
|
| Patient Compliance | 2 | 2010 | 402 | 0.080 |
Why?
|
| Skin Diseases | 2 | 2008 | 122 | 0.080 |
Why?
|
| Plutonium | 1 | 2010 | 49 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 100 | 0.080 |
Why?
|
| Renin | 1 | 2009 | 96 | 0.080 |
Why?
|
| Interviews as Topic | 4 | 2009 | 392 | 0.080 |
Why?
|
| Research Personnel | 2 | 2020 | 83 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2010 | 195 | 0.080 |
Why?
|
| Regression Analysis | 4 | 2008 | 737 | 0.080 |
Why?
|
| Mammography | 1 | 1991 | 310 | 0.080 |
Why?
|
| Georgia | 3 | 2006 | 161 | 0.080 |
Why?
|
| Pan American Health Organization | 2 | 2018 | 6 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 615 | 0.080 |
Why?
|
| Cardiography, Impedance | 1 | 2007 | 14 | 0.080 |
Why?
|
| Caribbean Region | 2 | 2018 | 10 | 0.080 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 63 | 0.080 |
Why?
|
| Diagnosis, Oral | 1 | 2007 | 14 | 0.070 |
Why?
|
| Perinatology | 2 | 1984 | 8 | 0.070 |
Why?
|
| Lipoproteins, VLDL | 2 | 2004 | 32 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 180 | 0.070 |
Why?
|
| Diabetic Foot | 1 | 2007 | 33 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 627 | 0.070 |
Why?
|
| Tobacco Use Cessation | 1 | 2007 | 44 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 146 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 50 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2008 | 186 | 0.070 |
Why?
|
| Educational Measurement | 2 | 2007 | 254 | 0.070 |
Why?
|
| Infant Mortality | 2 | 2003 | 59 | 0.070 |
Why?
|
| Carotid Artery, Common | 1 | 2006 | 25 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2008 | 649 | 0.070 |
Why?
|
| Goals | 2 | 2018 | 65 | 0.070 |
Why?
|
| Problem-Based Learning | 1 | 2007 | 72 | 0.070 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2005 | 4 | 0.070 |
Why?
|
| Geographic Information Systems | 1 | 2006 | 34 | 0.070 |
Why?
|
| Kazakhstan | 2 | 2018 | 4 | 0.070 |
Why?
|
| Body Image | 1 | 2007 | 100 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 334 | 0.070 |
Why?
|
| Smoking Prevention | 1 | 2007 | 259 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 511 | 0.070 |
Why?
|
| Calcinosis | 1 | 2007 | 241 | 0.070 |
Why?
|
| Diet Therapy | 1 | 2005 | 22 | 0.060 |
Why?
|
| Epidemiologic Studies | 2 | 2005 | 33 | 0.060 |
Why?
|
| Fetal Development | 1 | 2005 | 70 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 3 | 2018 | 329 | 0.060 |
Why?
|
| Government Regulation | 2 | 2016 | 46 | 0.060 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 83 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 378 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2009 | 1330 | 0.060 |
Why?
|
| Chest Pain | 1 | 2005 | 151 | 0.060 |
Why?
|
| Biomarkers | 3 | 2009 | 1593 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 951 | 0.060 |
Why?
|
| Maternal Exposure | 1 | 2004 | 75 | 0.060 |
Why?
|
| Enalapril | 1 | 2004 | 86 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2005 | 175 | 0.060 |
Why?
|
| Wales | 1 | 2003 | 3 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2004 | 113 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2004 | 184 | 0.060 |
Why?
|
| Tetrazoles | 1 | 2004 | 160 | 0.060 |
Why?
|
| Diabetic Retinopathy | 1 | 2004 | 110 | 0.050 |
Why?
|
| Prekallikrein | 1 | 2003 | 66 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2006 | 346 | 0.050 |
Why?
|
| Faculty, Medical | 2 | 2020 | 110 | 0.050 |
Why?
|
| Health Behavior | 3 | 2013 | 458 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2013 | 216 | 0.050 |
Why?
|
| Secondary Prevention | 2 | 2014 | 291 | 0.050 |
Why?
|
| Policy | 1 | 2022 | 58 | 0.050 |
Why?
|
| Smoking Cessation | 2 | 2010 | 1034 | 0.050 |
Why?
|
| Self Report | 2 | 2015 | 371 | 0.050 |
Why?
|
| Linear Models | 3 | 2009 | 521 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2009 | 551 | 0.050 |
Why?
|
| Football | 1 | 1982 | 25 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2023 | 159 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2006 | 450 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 1991 | 1536 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1745 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2023 | 369 | 0.050 |
Why?
|
| State Health Plans | 1 | 2001 | 13 | 0.050 |
Why?
|
| Swine, Miniature | 1 | 2001 | 45 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2015 | 186 | 0.050 |
Why?
|
| Midazolam | 1 | 2001 | 46 | 0.050 |
Why?
|
| Family | 1 | 2023 | 293 | 0.050 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 69 | 0.050 |
Why?
|
| Uric Acid | 1 | 2000 | 37 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 945 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 265 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2000 | 58 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2001 | 96 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 157 | 0.040 |
Why?
|
| Hypercholesterolemia | 2 | 2010 | 86 | 0.040 |
Why?
|
| Mentors | 1 | 2020 | 81 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2009 | 1242 | 0.040 |
Why?
|
| Air Pollutants | 1 | 2001 | 75 | 0.040 |
Why?
|
| Causality | 1 | 2000 | 82 | 0.040 |
Why?
|
| Protective Factors | 1 | 2020 | 24 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 96 | 0.040 |
Why?
|
| Preventive Medicine | 1 | 2000 | 48 | 0.040 |
Why?
|
| Christianity | 1 | 2000 | 16 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2019 | 10 | 0.040 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 1999 | 9 | 0.040 |
Why?
|
| Power Plants | 1 | 1999 | 6 | 0.040 |
Why?
|
| Educational Status | 2 | 2018 | 273 | 0.040 |
Why?
|
| Tritium | 1 | 1999 | 101 | 0.040 |
Why?
|
| Continuity of Patient Care | 2 | 1998 | 170 | 0.040 |
Why?
|
| Triglycerides | 3 | 2006 | 184 | 0.040 |
Why?
|
| South Africa | 1 | 2019 | 45 | 0.040 |
Why?
|
| Medical History Taking | 1 | 1980 | 94 | 0.040 |
Why?
|
| Universities | 1 | 1980 | 191 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1980 | 75 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2012 | 179 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 2223 | 0.040 |
Why?
|
| Legislation, Medical | 1 | 1998 | 8 | 0.040 |
Why?
|
| Education | 1 | 1999 | 83 | 0.040 |
Why?
|
| Automation | 1 | 2018 | 45 | 0.040 |
Why?
|
| Confusion | 1 | 2018 | 20 | 0.040 |
Why?
|
| Creatinine | 2 | 2013 | 243 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 37 | 0.040 |
Why?
|
| Calcium Channel Blockers | 2 | 2014 | 138 | 0.040 |
Why?
|
| Barbados | 1 | 2018 | 2 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2000 | 148 | 0.040 |
Why?
|
| Colombia | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cuba | 1 | 2018 | 8 | 0.040 |
Why?
|
| Physician's Role | 1 | 1999 | 116 | 0.040 |
Why?
|
| Chile | 1 | 2018 | 17 | 0.040 |
Why?
|
| Indians, North American | 1 | 2018 | 64 | 0.040 |
Why?
|
| Anniversaries and Special Events | 1 | 2018 | 12 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2018 | 73 | 0.040 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2018 | 8 | 0.040 |
Why?
|
| Volunteers | 1 | 1998 | 30 | 0.040 |
Why?
|
| Animals | 4 | 2019 | 20881 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2324 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2018 | 94 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 174 | 0.040 |
Why?
|
| Sampling Studies | 2 | 2003 | 80 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2018 | 1342 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2018 | 120 | 0.040 |
Why?
|
| Melanoma | 1 | 2001 | 335 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 211 | 0.040 |
Why?
|
| Survivors | 1 | 2020 | 256 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2013 | 373 | 0.040 |
Why?
|
| Program Development | 2 | 2015 | 240 | 0.040 |
Why?
|
| Thoracic Surgery | 1 | 1998 | 72 | 0.040 |
Why?
|
| Stroke, Lacunar | 1 | 2017 | 3 | 0.040 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 117 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2018 | 111 | 0.040 |
Why?
|
| Models, Economic | 1 | 2017 | 69 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2001 | 375 | 0.040 |
Why?
|
| Anesthesia, Dental | 1 | 1997 | 5 | 0.040 |
Why?
|
| Anesthesia, Local | 1 | 1997 | 14 | 0.040 |
Why?
|
| Vibration | 1 | 1997 | 32 | 0.030 |
Why?
|
| Internet | 2 | 2014 | 390 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 72 | 0.030 |
Why?
|
| Costa Rica | 1 | 1996 | 6 | 0.030 |
Why?
|
| Mortality, Premature | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2017 | 116 | 0.030 |
Why?
|
| Nephrology | 1 | 2016 | 43 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2077 | 0.030 |
Why?
|
| Cultural Characteristics | 1 | 2015 | 42 | 0.030 |
Why?
|
| Health Resources | 1 | 2015 | 76 | 0.030 |
Why?
|
| Denervation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 342 | 0.030 |
Why?
|
| Hypertension, Renal | 1 | 2015 | 29 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 239 | 0.030 |
Why?
|
| Publications | 1 | 2014 | 17 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2007 | 453 | 0.030 |
Why?
|
| Adiposity | 1 | 2015 | 88 | 0.030 |
Why?
|
| Health | 1 | 2014 | 26 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cholesterol, HDL | 2 | 2006 | 112 | 0.030 |
Why?
|
| Government | 1 | 2014 | 2 | 0.030 |
Why?
|
| Survival Analysis | 2 | 1993 | 714 | 0.030 |
Why?
|
| Population | 1 | 2013 | 11 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 109 | 0.030 |
Why?
|
| Guatemala | 1 | 2013 | 9 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2013 | 39 | 0.030 |
Why?
|
| Jaundice, Obstructive | 1 | 2013 | 8 | 0.030 |
Why?
|
| Nurses | 1 | 2014 | 53 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2008 | 295 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2013 | 24 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 652 | 0.030 |
Why?
|
| Insecticides | 1 | 2013 | 43 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 2013 | 66 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 565 | 0.030 |
Why?
|
| Air Pollution | 1 | 2013 | 54 | 0.030 |
Why?
|
| Diuretics | 2 | 2005 | 97 | 0.030 |
Why?
|
| Pain | 1 | 1997 | 472 | 0.030 |
Why?
|
| Pharmacists | 1 | 2014 | 125 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 267 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2015 | 183 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2791 | 0.030 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2013 | 79 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 1213 | 0.030 |
Why?
|
| Metals | 1 | 2013 | 100 | 0.030 |
Why?
|
| Propensity Score | 1 | 2013 | 117 | 0.030 |
Why?
|
| Reference Values | 1 | 2014 | 579 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2005 | 189 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 500 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 106 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 177 | 0.030 |
Why?
|
| Chicago | 1 | 2012 | 30 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2015 | 356 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2015 | 705 | 0.030 |
Why?
|
| Leisure Activities | 1 | 1992 | 22 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 233 | 0.020 |
Why?
|
| Medicaid | 2 | 2006 | 302 | 0.020 |
Why?
|
| Palpation | 1 | 1991 | 21 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2012 | 107 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2013 | 279 | 0.020 |
Why?
|
| Patient Care Management | 1 | 2011 | 40 | 0.020 |
Why?
|
| Social Responsibility | 1 | 2010 | 39 | 0.020 |
Why?
|
| Smad1 Protein | 1 | 2010 | 10 | 0.020 |
Why?
|
| Water Pollution | 1 | 2010 | 10 | 0.020 |
Why?
|
| Mexico | 1 | 2010 | 38 | 0.020 |
Why?
|
| Russia | 1 | 2010 | 8 | 0.020 |
Why?
|
| Radionuclide Generators | 1 | 2010 | 6 | 0.020 |
Why?
|
| Air Pollutants, Radioactive | 1 | 2010 | 11 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1992 | 222 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 207 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 159 | 0.020 |
Why?
|
| Nitrates | 1 | 2010 | 61 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 84 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 711 | 0.020 |
Why?
|
| Medicare | 1 | 2012 | 319 | 0.020 |
Why?
|
| Potassium, Dietary | 1 | 2009 | 3 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Calcium, Dietary | 1 | 2009 | 35 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 2009 | 37 | 0.020 |
Why?
|
| Elasticity | 1 | 2009 | 103 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 266 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 123 | 0.020 |
Why?
|
| Magnesium | 1 | 2009 | 110 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 490 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 536 | 0.020 |
Why?
|
| Infliximab | 1 | 2008 | 16 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 85 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1990 | 224 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1991 | 219 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 1015 | 0.020 |
Why?
|
| Weight Loss | 1 | 2010 | 319 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 245 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 786 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 316 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2008 | 110 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 36 | 0.020 |
Why?
|
| Rural Population | 2 | 2007 | 398 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 8474 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 371 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 567 | 0.020 |
Why?
|
| Body Constitution | 1 | 2006 | 24 | 0.020 |
Why?
|
| Control Groups | 1 | 2006 | 10 | 0.020 |
Why?
|
| Lipids | 1 | 2008 | 298 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 2176 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 224 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 911 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 255 | 0.020 |
Why?
|
| Knowledge | 1 | 2005 | 18 | 0.020 |
Why?
|
| Diet Surveys | 1 | 1985 | 24 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 483 | 0.020 |
Why?
|
| Habits | 1 | 2005 | 14 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2005 | 61 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 188 | 0.020 |
Why?
|
| Antibodies | 1 | 2006 | 241 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 175 | 0.020 |
Why?
|
| Mental Recall | 1 | 1985 | 72 | 0.020 |
Why?
|
| Random Allocation | 1 | 2006 | 442 | 0.020 |
Why?
|
| Syndrome | 1 | 2005 | 255 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2008 | 448 | 0.020 |
Why?
|
| District of Columbia | 1 | 2004 | 23 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2005 | 119 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 82 | 0.020 |
Why?
|
| Students | 1 | 2007 | 233 | 0.020 |
Why?
|
| Length of Stay | 1 | 2008 | 780 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2006 | 275 | 0.010 |
Why?
|
| Lipoproteins, IDL | 1 | 2003 | 8 | 0.010 |
Why?
|
| Medical Audit | 1 | 2003 | 44 | 0.010 |
Why?
|
| Cholesterol, VLDL | 1 | 2003 | 17 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 121 | 0.010 |
Why?
|
| Birth Certificates | 1 | 2003 | 16 | 0.010 |
Why?
|
| Kininogen, High-Molecular-Weight | 1 | 2003 | 23 | 0.010 |
Why?
|
| Factor XII | 1 | 2003 | 96 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2003 | 87 | 0.010 |
Why?
|
| Kinins | 1 | 2003 | 109 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2550 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 362 | 0.010 |
Why?
|
| Computers | 1 | 1982 | 63 | 0.010 |
Why?
|
| Kallikreins | 1 | 2003 | 323 | 0.010 |
Why?
|
| Aviation | 1 | 2001 | 13 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2003 | 158 | 0.010 |
Why?
|
| Canada | 1 | 2001 | 267 | 0.010 |
Why?
|
| Achievement | 1 | 2000 | 22 | 0.010 |
Why?
|
| Schools | 1 | 1982 | 156 | 0.010 |
Why?
|
| Smoke | 1 | 2001 | 46 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2001 | 169 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2003 | 383 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2001 | 136 | 0.010 |
Why?
|
| Radioactive Waste | 1 | 1999 | 12 | 0.010 |
Why?
|
| Germany | 1 | 1999 | 67 | 0.010 |
Why?
|
| Office Visits | 1 | 1999 | 83 | 0.010 |
Why?
|
| Drug Costs | 1 | 1999 | 87 | 0.010 |
Why?
|
| Swine | 1 | 2001 | 672 | 0.010 |
Why?
|
| Governing Board | 1 | 1998 | 12 | 0.010 |
Why?
|
| Learning | 1 | 2000 | 186 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 1615 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 1998 | 79 | 0.010 |
Why?
|
| Students, Medical | 1 | 2000 | 210 | 0.010 |
Why?
|
| General Surgery | 1 | 1998 | 95 | 0.010 |
Why?
|
| Bicuspid | 1 | 1997 | 9 | 0.010 |
Why?
|
| Motivation | 1 | 2001 | 561 | 0.010 |
Why?
|
| Injections | 1 | 1997 | 119 | 0.010 |
Why?
|
| Maxilla | 1 | 1997 | 63 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1997 | 117 | 0.010 |
Why?
|
| Pain Measurement | 1 | 1997 | 328 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1997 | 1738 | 0.010 |
Why?
|
| Obstetrics | 1 | 1989 | 44 | 0.000 |
Why?
|
| Gynecology | 1 | 1989 | 46 | 0.000 |
Why?
|
| Internal Medicine | 1 | 1989 | 118 | 0.000 |
Why?
|
| Family Practice | 1 | 1989 | 312 | 0.000 |
Why?
|
| Postnatal Care | 1 | 1984 | 16 | 0.000 |
Why?
|
| Fetal Death | 1 | 1984 | 49 | 0.000 |
Why?
|
| Hospitals, Community | 1 | 1984 | 64 | 0.000 |
Why?
|
| Acute Disease | 1 | 1981 | 658 | 0.000 |
Why?
|